SEC Tracker
Get the app

Iambic Therapeutics IAM

Iambic Therapeutics goes public

Securities offering

Form
424B4
Filed
Importance
Routine
  1. 9,375,000 shares offered at $16.00 each
  2. Proceeds to company: $139.5M
  3. ARK Investment and Duquesne interested in $60M purchase
  4. Underwriters can buy 1,406,250 additional shares

Written from the 424B4 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Iambic Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float not reported.

  1. Adaptimmune Therapeutics ADAP
  2. Adverum Biotechnologies ADVM
  3. AgomAb Therapeutics AGMB
  4. Alvotech ALVO
  5. Argenx ARGX